Results 41 to 50 of about 126 (71)

Biomarkers of sequela in adult patients convalescing from COVID-19. [PDF]

open access: yesAdv Biomark Sci Technol, 2022
Marsán-Suárez V   +29 more
europepmc   +1 more source

Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study. [PDF]

open access: yesPLoS One, 2023
Venegas-Rodríguez R   +12 more
europepmc   +1 more source

Protein kinase CK2: a potential therapeutic target for diverse human diseases. [PDF]

open access: yesSignal Transduct Target Ther, 2021
Borgo C   +4 more
europepmc   +1 more source

Recent advances in respiratory immunization: A focus on COVID-19 vaccines. [PDF]

open access: yesJ Control Release, 2023
He X, Chen X, Wang H, Du G, Sun X.
europepmc   +1 more source

The landscape of COVID-19 clinical trials in Latin America and the Caribbean: assessment and challenges. [PDF]

open access: yesRev Panam Salud Publica, 2020
Carracedo S   +5 more
europepmc   +1 more source

COVID-19: Clinical status of vaccine development to date. [PDF]

open access: yesBr J Clin Pharmacol, 2023
Kumar S   +4 more
europepmc   +1 more source

Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study. [PDF]

open access: yesLancet Reg Health Am, 2022
Más-Bermejo PI   +15 more
europepmc   +1 more source

[The landscape of COVID-19 clinical trials in Latin America and the Caribbean: assessment and challenges]. [PDF]

open access: yesRev Panam Salud Publica, 2021
Carracedo S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy